Company Filing History:
Years Active: 2010-2011
Title: Innovations by Sang-Soo Bang
Introduction
Sang-Soo Bang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pain management through his innovative research and patents. With a total of two patents to his name, his work focuses on the modulation of specific receptors involved in pain perception.
Latest Patents
One of his latest patents is titled "Compound for inhibiting TRPA1 function and use thereof." This invention relates to a TRPA1 activation inhibitor, specifically an inhibitor containing isopentenyl pyrophosphate. The method described involves administering isopentenyl pyrophosphate to a subject to inhibit pain caused by TRPA1 activation. This compound can potentially lead to the development of effective pain inhibitors with fewer side effects.
Another significant patent by Sang-Soo Bang is "Compound containing farnesyl diphosphate for modulating TRPV3 function and use thereof." This invention outlines a method for activating TRPV3 (transient receptor potential vanilloid 3) using farnesyl diphosphate (FPP). The FPP compound exhibits TRPV3 specific activity, making it valuable for studying TRPV3 mechanisms and functions, as well as for developing TRPV3-based pain relievers.
Career Highlights
Sang-Soo Bang is affiliated with the Korea University Industry and Academic Collaboration Foundation, where he continues to advance his research in pain management and receptor modulation. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Sang-Soo Bang collaborates with Sun Wook Hwang, contributing to the innovative research environment at their institution.
Conclusion
Sang-Soo Bang's contributions to the field of pain management through his patents highlight his innovative approach to addressing complex medical challenges. His work has the potential to significantly impact the development of new pain relief therapies.